SELECTION OF NON-SMALL CELL LUNG CANCER PATIENTS FOR INTERCALATED CHEMOTHERAPY AND TYROSINE KINASE INHIBITORS. Radiol Oncol [Internet]. 2017 Sep. 10 [cited 2026 Sep. 25];51(3). Available from: https://www.radioloncol.com/index.php/ro/article/view/2816